- Home
- SONN vs AZTR Comparison
SONN vs AZTR Comparison
Compare SONN & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- AZTR
- Stock Information
- Founded
- SONN N/A
- AZTR 2014
- Country
- SONN United States
- AZTR United States
- Employees
- SONN N/A
- AZTR N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- AZTR Biotechnology: Pharmaceutical Preparations
- Sector
- SONN Health Care
- AZTR Health Care
- Exchange
- SONN Nasdaq
- AZTR Nasdaq
- Market Cap
- SONN 4.6M
- AZTR 5.2M
- IPO Year
- SONN N/A
- AZTR 2023
- Fundamental
- Price
- SONN $1.28
- AZTR $0.30
- Analyst Decision
- SONN Strong Buy
- AZTR
- Analyst Count
- SONN 2
- AZTR 0
- Target Price
- SONN $38.00
- AZTR N/A
- AVG Volume (30 Days)
- SONN 31.5K
- AZTR 3.4M
- Earning Date
- SONN 05-16-2025
- AZTR 05-20-2025
- Dividend Yield
- SONN N/A
- AZTR N/A
- EPS Growth
- SONN N/A
- AZTR N/A
- EPS
- SONN N/A
- AZTR N/A
- Revenue
- SONN $1,000,000.00
- AZTR $7,500.00
- Revenue This Year
- SONN $5,376.22
- AZTR N/A
- Revenue Next Year
- SONN N/A
- AZTR N/A
- P/E Ratio
- SONN N/A
- AZTR N/A
- Revenue Growth
- SONN 674.14
- AZTR N/A
- 52 Week Low
- SONN $1.10
- AZTR $0.23
- 52 Week High
- SONN $16.00
- AZTR $12.00
- Technical
- Relative Strength Index (RSI)
- SONN 44.48
- AZTR 47.11
- Support Level
- SONN $1.30
- AZTR $0.28
- Resistance Level
- SONN $1.37
- AZTR $0.34
- Average True Range (ATR)
- SONN 0.09
- AZTR 0.03
- MACD
- SONN -0.01
- AZTR -0.00
- Stochastic Oscillator
- SONN 13.79
- AZTR 19.23
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.